| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/30/2011 | WO2011077787A1 Method for producing polypeptide derivative having peptide main chain cleavable in mild environment |
| 06/30/2011 | WO2011075838A1 Method of treating or preventing hearing loss |
| 06/30/2011 | WO2010148065A3 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1 |
| 06/30/2011 | WO2010137900A3 Selective infracted-tissue-targeting bacteria and use thereof |
| 06/30/2011 | US20110162096 Gene Therapy Using Transposon-Based Vectors |
| 06/30/2011 | US20110160289 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 06/30/2011 | US20110160288 Oip5 as a target gene for cancer therapy and diagnosis |
| 06/30/2011 | US20110160286 Allele-specific rna interference |
| 06/30/2011 | US20110160278 Methods For Selectively Modulating Survivin Apoptosis Pathways |
| 06/30/2011 | US20110159587 Chimeric Molecules to Modulate Gene Expression |
| 06/30/2011 | US20110159585 Directly injectable formulations which provide enhanced cryoprotection of cell products |
| 06/30/2011 | US20110159532 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 06/30/2011 | US20110159075 Compositions and systems for forming crosslinked biomaterials and methods of preparation and use |
| 06/30/2011 | US20110159070 Biomaterials and implants for enhanced cartilage formation, and methods for making and using them |
| 06/30/2011 | US20110159039 Eliciting hcv-specific antibodies |
| 06/30/2011 | US20110159032 Modified vaccinia virus ankara for the vaccination of neonates |
| 06/30/2011 | US20110158993 Train-R: A Cysteine Rich Member of the TNF-Receptor Family |
| 06/30/2011 | US20110158965 Cardiac Muscle Regeneration Using Mesenchymal Stem Cells |
| 06/30/2011 | US20110158964 Cardiac Muscle Regeneration Using Mesenchymal Stem Cells |
| 06/30/2011 | US20110158947 Sulfonylurea receptor and means for treating ischaemia |
| 06/30/2011 | US20110158937 Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 06/30/2011 | US20110158936 Use of interleukin 17e for the treatment of cancer |
| 06/30/2011 | CA2782375A1 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2 |
| 06/30/2011 | CA2782373A1 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
| 06/29/2011 | EP2339035A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/29/2011 | EP2339020A1 Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A) |
| 06/29/2011 | EP2338996A2 Methods and compositions for reducing viral genome amounts in a target cell |
| 06/29/2011 | EP2338995A2 Interfering RNA duplex having blunt-ends and 3'-modifications |
| 06/29/2011 | EP2338994A1 Regulation of oncogenes by microRNAs |
| 06/29/2011 | EP2338993A1 Regulation of oncogenes by microRNAs |
| 06/29/2011 | EP2338913A1 Chromosome 13-linked breast cancer susceptibility gene |
| 06/29/2011 | EP2338906A1 Compostion and methods for increasing bone mineralization |
| 06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 06/29/2011 | EP2338524A1 Combined gene therapy for the treatment of macroscopic gliomas |
| 06/29/2011 | EP2338519A1 Agent for treating myelofibrosis |
| 06/29/2011 | EP2338507A1 Method of treating malignancies through induction of blood immune responses |
| 06/29/2011 | EP2338506A2 Combinations of tumor-associated antigens for the treatment of various types of cancers |
| 06/29/2011 | EP1737493B1 Inhibitors of insulin-like growth factor receptor -1 for inhibiting tumor cell growth |
| 06/29/2011 | EP1233958B1 Inhibitors of histone deacetylase |
| 06/29/2011 | EP1226233B1 Multipotent adult stem cells and methods for isolation |
| 06/29/2011 | EP1183348B1 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 06/29/2011 | CN1968608B Improved modalities for the treatment of degenerative diseases of the retina |
| 06/29/2011 | CN1606565B Nucleic acids encoding recominant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 06/29/2011 | CN102112146A Immunity inducer |
| 06/29/2011 | CN102112110A Novel compositions for the in vivo delivery of RNAi agents |
| 06/29/2011 | CN102108369A Application of DNA repair protein RAD51 in preparing medicament for treating osteosarcoma |
| 06/29/2011 | CN102108356A Novel promoter and virus vector containing same |
| 06/29/2011 | CN102108354A siRNA with function of inhibiting replication of influenza A virus and coding sequence thereof |
| 06/29/2011 | CN102108336A Recombinant adenovirus vaccine containing EB (Epstein-Barr) virus membrane protein gp350/220, gp85, gp78 or gp25 gene |
| 06/29/2011 | CN102107008A DNA damage repair inhibitors for treatment of cancer |
| 06/29/2011 | CN101716346B Supramolecular hydrogel gene vector material, and preparation method and application thereof |
| 06/29/2011 | CN101579528B HIV composite multi-epitope DNA vaccine and application thereof |
| 06/29/2011 | CN101440126B Acquisition and use of homing polypeptide with targeting specificity related to tumor and metastases thereof |
| 06/29/2011 | CN101368187B Recombinant human FUS1 and human IL-12 dual-gene expression carrier, liposome complexes, preparation method and application thereof |
| 06/29/2011 | CN101233231B Anti-obesity agent and anti-obesity food |
| 06/28/2011 | US7968695 Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of Eimeria maxima and their uses |
| 06/28/2011 | US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby |
| 06/28/2011 | US7968526 Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968340 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 06/28/2011 | US7968337 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 06/28/2011 | US7968333 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 06/28/2011 | US7968332 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 06/28/2011 | US7968303 Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1) |
| 06/28/2011 | US7968301 Method of modulating Sost binding to LRP |
| 06/28/2011 | US7968298 attenuated DNA viruses which increases production of chemokines |
| 06/28/2011 | US7968286 Settings for recombinant adenoviral-based vaccines |
| 06/28/2011 | US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 06/28/2011 | US7968123 Complexing agents for compositions containing inclusion complexes |
| 06/28/2011 | US7968099 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 06/28/2011 | US7968087 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| 06/28/2011 | US7968086 Genetically stable enterovirus expression vector with replaced stem loop VI |
| 06/28/2011 | US7968085 Hydrogel formulations |
| 06/28/2011 | CA2332179C Uses of dna-pk |
| 06/28/2011 | CA2315976C Serine protease inhibitors |
| 06/28/2011 | CA2209300C Redirection of cellular immunity by receptor chimeras |
| 06/28/2011 | CA2190293C Method of cancer treatment by p53 protein control |
| 06/23/2011 | WO2011074652A1 Nucleic acid capable of inhibiting expression of hif-2α |
| 06/23/2011 | WO2011074564A1 Method of producing adenovirus vectors |
| 06/23/2011 | WO2011017456A3 Localized delivery of nanoparticles for therapeutic and diagnostic applications |
| 06/23/2011 | WO2011017404A3 Retroelements and mental disorders and methods of measuring l1 retrotransposition |
| 06/23/2011 | WO2011011700A3 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
| 06/23/2011 | WO2010148050A3 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene |
| 06/23/2011 | US20110154517 Disorders of vasoregulation and methods of diagnosing them |
| 06/23/2011 | US20110152359 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising threreof |
| 06/23/2011 | US20110152354 Bispecific Oligonucleotide for the Treatment of CNS Malignancies |
| 06/23/2011 | US20110152353 Double-stranded polynucleotide |
| 06/23/2011 | US20110152347 Methods and compositions for controlling efficacy of RNA silencing |
| 06/23/2011 | US20110152167 Biodegradable block polymers for drug delivery, and methods related thereto |
| 06/23/2011 | US20110151558 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 06/23/2011 | US20110151539 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 06/23/2011 | US20110151473 Polynucleotides and Polypeptides Encoding Receptors |
| 06/23/2011 | US20110151472 Novel means for the diagnosis and therapy of ctcl |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110150975 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 06/23/2011 | US20110150938 Supercrystalline Colloidal Particles and Method of Production |
| 06/23/2011 | US20110150921 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 06/23/2011 | US20110150919 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/23/2011 | US20110150910 Methods of inducing an immune response |
| 06/23/2011 | US20110150883 Compositions and methods for the therapy and diagnosis of breast cancer |